National multicentric M13 Stem Cell Trial reports negative outcome - Need to look at VSELs as an alternative to bone marrow MNCs for cardiac regeneration

Authors′ response

“…Hence, the contention that no articles published from 2013-2015 having been cited should not be surprising. At no stage, even remotely, have we suggested that no progress has been made in this field as mentioned in the letter3. On the contrary, we agree that significant progress has been made in the field of stem cells and mesenchymal stem cells (MSC) worldwide.…”